Factors Determining δ-Bilirubin Levels in Infants With Biliary Atresia.
Wen Ye, Philip Rosenthal, John C Magee...
https://pubmed.ncbi.nlm.nih.gov/25564820/Actively Recruiting
Led by Arbor Research Collaborative for Health · Updated on 2026-06-04
1000
Participants Needed
16
Research Sites
N/A
Total Duration
Researchers are studying infants with cholestasis, including conditions like biliary atresia and idiopathic neonatal hepatitis that cause prolonged jaundice and high bilirubin levels after the newborn period. The Childhood Liver Disease Research Network ChiLDReN aims to create a database of clinical information and biological samples from affected children to support research and clinical trials on these serious liver diseases in children. This project collects detailed clinical data, laboratory results, and biological samples such as blood and tissue from infants diagnosed or suspected to have biliary atresia or other neonatal liver diseases. Infants diagnosed with biliary atresia are followed closely during their first year, at 18 months, annually up to age 10, and then every two years, or until liver transplantation occurs. Infants with other cholestatic diagnoses exit the study after diagnosis is confirmed. Participants undergo routine clinical care and evaluations, with data entered into a secure national research database. Blood samples are collected during clinically indicated procedures when possible. Researchers measure disease progression over time at multiple intervals from baseline through 20 years of age. The study involves long-term follow-up of outcomes and data are securely stored and eventually transferred to a national data repository.
CONDITIONS
A Prospective Database of Infants With Cholestasis
M
Melissa Sexton, BBA, CCRP
M
Melissa Sexton, BBA
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Arbor Research Collaborative for Health
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit
Duration - Up to diagnosis determination
Participants undergo diagnostic assessments as part of the clinical standard of care to determine their diagnosis and disease severity.
Visits as part of routine clinical care
Duration - Up to 20 years
Participants diagnosed with biliary atresia are followed intensively for the first year, then at 18 months, annually up to 10 years, and biannually thereafter until liver transplantation or study end. Participants with other diagnoses exit the study at diagnosis determination.
Multiple visits: frequent in the first year, then at 18 months, annually up to year 10, then biannually
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Wen Ye, Philip Rosenthal, John C Magee...
https://pubmed.ncbi.nlm.nih.gov/25564820/Jeffrey Teckman, Philip Rosenthal, Rosalinda V Ignacio...
https://pubmed.ncbi.nlm.nih.gov/38055647/Kazuhiko Bessho, Reena Mourya, Pranavkumar Shivakumar...
https://pubmed.ncbi.nlm.nih.gov/24493287/Adam M Zahm, Nicholas J Hand, LaTasha A Boateng...
https://pubmed.ncbi.nlm.nih.gov/22732895/Benjamin L Shneider, Bob Abel, Barbara Haber...
https://pubmed.ncbi.nlm.nih.gov/22903006/Sarah Kemme, Jennifer D Canniff, Amy G Feldman...
https://pubmed.ncbi.nlm.nih.gov/37471052/Vicky L Ng, Lisa G Sorensen, Estella M Alonso...
https://pubmed.ncbi.nlm.nih.gov/29519540/Paula M Hertel, Kieran Hawthorne, Sehee Kim...
https://pubmed.ncbi.nlm.nih.gov/34310436/Benjamin L Shneider, John C Magee, Saul J Karpen...
https://pubmed.ncbi.nlm.nih.gov/26725209/Arbor Research Collaborative for Health
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor